Valeant Pharmaceuticals International Inc (NYSE:VRX)

210.42
Delayed Data
As of Apr 24
 +1.03 / +0.49%
Today’s Change
106.00
Today|||52-Week Range
211.57
+47.03%
Year-to-Date

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 222.50, with a high estimate of 243.00 and a low estimate of 170.00. The median estimate represents a +5.74% increase from the last price of 210.42.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.33
Sales
$2.1B
Reporting Date
Apr 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.81%
 
 
 
 
 
 
Growthannually 26.62%
 
 
 
 
 
 

Sales

Growthquarterly -5.88%
 
 
 
 
 
 
Growthannually 21.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account